International Psoriasis Council
THE LATEST FROM IPC, INDUSTRY, AND NEWS
Biologics and biosimilars have created many new options in psoriasis treatment for patients worldwide, but patients worldwide face barriers to acquiring them. This has led IPC Councilor Dr. Matias Maskin to reconsider what success means for psoriasis patients.
The International Psoriasis Council (IPC) and Scientific Education Support (SES) are excited to announce a strategic collaboration aimed to improve awareness, knowledge, and understanding of psoriasis, psoriatic arthritis, and other related diseases.
The monkeypox outbreak has had a significant impact all across the globe. Here’s what to know about monkeypox symptoms, treatment, and prevention.
The European Academy of Dermatology and Venereology (EADV) organized its 31st congress in Milano, Italy, under the parole “Designing the Future of Dermatology and Venereology.” The event took place from September 7 – 10, 2022, as a hybrid meeting with the option of attending virtually or in person. The following congress report includes fifteen summaries of presentations focusing on psoriasis. You can download the full report or read the summary.
IPC is pleased to introduce and welcome our five newest Councilors for 2022: Pravit Asawanonda, Sunil Dogra, Benjamin Ehst, Filip Rob, and Tsen-Fang Tsai. These individuals were confirmed by the IPC Board of Directors during the European Academy of Dermatology and Venereology (EADV) Congress in September.
Psoriasis and tuberculosis have long gone hand-in-hand. This is especially true in certain parts of the world, where latent tuberculosis continues to be widespread. With one-quarter of the global population estimated to have latent tuberculosis, guidelines to properly screen for and treat tuberculosis in psoriasis patients are critical.
The IPC is a proud supporter of World Psoriasis Day by uniting for action with IFPA to advance care and change the perception of psoriatic disease. Watch the video below to hear IPC’s key opinion leaders from around the world discuss this year’s theme – psoriasis and its impact on mental health.
Prof. Christine Bundy shares how clinicians can center mental health in psoriasis care — and what to look out for in your patients.
The Global Psoriasis Atlas (GPA) is a joint project of the ILDS (International League of Dermatological Societies), IFPA (International Federation of Psoriasis Associations), and IPC (International Psoriasis Council) delivered by staff based at the University of Manchester. Its goal is to provide the benchmark on the burden of psoriasis in all countries and regions throughout the world using comprehensive epidemiological data to inform research, policy, and healthcare.
Personalized care has become increasingly utilized in the past two few decades, evolving as we have gained a greater understanding of the human genome and recognized the importance of shifting away from a “one size fits all” approach to medicine.
New resource page that includes the latest articles, downloads, and related press releases on GPP to assist with diagnosing and treating this rare disease.
Patients with psoriasis are at increased risk for cardiovascular disease —and lack of physical activity may be a driving cause.
